Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling
- PMID: 33580861
- DOI: 10.1007/s11011-021-00676-w
Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling
Abstract
Phenylketonuria (PKU) is one of the commonest inborn error of amino acid metabolism. Before mass neonatal screening was possible, and the success of introducing diet therapy right after birth, the typical clinical finds in patients ranged from intellectual disability, epilepsy, motor deficits to behavioral disturbances and other neurological and psychiatric symptoms. Since early diagnosis and treatment became widespread, usually only those patients who do not strictly follow the diet present psychiatric, less severe symptoms such as anxiety, depression, sleep pattern disturbance, and concentration and memory problems. Despite the success of low protein intake in preventing otherwise severe outcomes, PKU's underlying neuropathophysiology remains to be better elucidated. Oxidative stress has gained acceptance as a disturbance implicated in the pathogenesis of PKU. The conception of oxidative stress has evolved to comprehend how it could interfere and ultimately modulate metabolic pathways regulating cell function. We summarize the evidence of oxidative damage, as well as compromised antioxidant defenses, from patients, animal models of PKU, and in vitro experiments, discussing the possible clinical significance of these findings. There are many studies on oxidative stress and PKU, but only a few went further than showing macromolecular damage and disturbance of antioxidant defenses. In this review, we argue that these few studies may point that oxidative stress may also disturb redox signaling in PKU, an aspect few authors have explored so far. The reported effect of phenylalanine on the expression or activity of enzymes participating in metabolic pathways known to be responsive to redox signaling might be mediated through oxidative stress.
Keywords: Oxidative stress; Phenylketonuria; Redox signaling.
Similar articles
-
Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.Metab Brain Dis. 2019 Dec;34(6):1649-1660. doi: 10.1007/s11011-019-00472-7. Epub 2019 Jul 27. Metab Brain Dis. 2019. PMID: 31352540
-
Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C.J Neurosci Res. 2002 Aug 15;69(4):550-8. doi: 10.1002/jnr.10307. J Neurosci Res. 2002. PMID: 12210848
-
Antioxidant treatment strategies for hyperphenylalaninemia.Metab Brain Dis. 2013 Dec;28(4):541-50. doi: 10.1007/s11011-013-9414-2. Epub 2013 May 9. Metab Brain Dis. 2013. PMID: 23657560 Review.
-
Oxidative stress in phenylketonuria: what is the evidence?Cell Mol Neurobiol. 2011 Jul;31(5):653-62. doi: 10.1007/s10571-011-9693-2. Epub 2011 Apr 23. Cell Mol Neurobiol. 2011. PMID: 21516352 Review.
-
Oxidative stress in phenylketonuria: future directions.J Inherit Metab Dis. 2012 May;35(3):381-98. doi: 10.1007/s10545-011-9417-2. Epub 2011 Nov 25. J Inherit Metab Dis. 2012. PMID: 22116469 Review.
Cited by
-
Vitamin C injection improves antioxidant stress capacity through regulating blood metabolism in post-transit yak.Sci Rep. 2023 Jun 23;13(1):10233. doi: 10.1038/s41598-023-36779-w. Sci Rep. 2023. PMID: 37353533 Free PMC article.
-
Engineering Organoids for in vitro Modeling of Phenylketonuria.Front Mol Neurosci. 2022 Jan 10;14:787242. doi: 10.3389/fnmol.2021.787242. eCollection 2021. Front Mol Neurosci. 2022. PMID: 35082602 Free PMC article. Review.
-
An Updated PAH Mutational Spectrum of Phenylketonuria in Mexican Patients Attending a Single Center: Biochemical, Clinical-Genotyping Correlations.Genes (Basel). 2021 Oct 23;12(11):1676. doi: 10.3390/genes12111676. Genes (Basel). 2021. PMID: 34828281 Free PMC article.
References
-
- Anderson PJ, Leuzzi V (2010) White matter pathology in phenylketonuria. Mol Genet Metab 99(Suppl 1):S3–S9. https://doi.org/10.1016/j.ymgme.2009.10.005 - DOI - PubMed
-
- Artuch R, Vilaseca MA, Moreno J, Lambruschini N, Cambra FJ, Campistol J (1999) Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am J Clin Nutr 70:892–895. https://doi.org/10.1093/ajcn/70.5.892 - DOI - PubMed
-
- Artuch R, Colome C, Vilaseca MA, Sierra C, Cambra FJ, Lambruschini N, Campistol J (2001) Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. J Inherit Metab Dis 24:359–366. https://doi.org/10.1023/a:1010500502275 - DOI - PubMed
-
- Artuch R et al (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203. https://doi.org/10.1016/j.clinbiochem.2003.10.017 - DOI - PubMed
-
- Azabdaftari A, van der Giet M, Schuchardt M, Hennermann JB, Plockinger U, Querfeld U (2019) The cardiovascular phenotype of adult patients with phenylketonuria. Orphanet J Rare Dis 14:213. https://doi.org/10.1186/s13023-019-1188-0 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical